HK1248218A1 - 作為毒蕈碱m1受體和/或m4受體的激動劑的螺環化合物 - Google Patents
作為毒蕈碱m1受體和/或m4受體的激動劑的螺環化合物Info
- Publication number
- HK1248218A1 HK1248218A1 HK18107567.8A HK18107567A HK1248218A1 HK 1248218 A1 HK1248218 A1 HK 1248218A1 HK 18107567 A HK18107567 A HK 18107567A HK 1248218 A1 HK1248218 A1 HK 1248218A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- receptor
- muscarinic
- agonists
- spirocyclic compounds
- spirocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1504675.8A GB201504675D0 (en) | 2015-03-19 | 2015-03-19 | Pharmaceutical compounds |
PCT/GB2016/050771 WO2016147011A1 (en) | 2015-03-19 | 2016-03-21 | Spirocyclic compounds as agonists of the muscarinic m1 receptor and/or m4 receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1248218A1 true HK1248218A1 (zh) | 2018-10-12 |
Family
ID=53052080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18107567.8A HK1248218A1 (zh) | 2015-03-19 | 2018-06-11 | 作為毒蕈碱m1受體和/或m4受體的激動劑的螺環化合物 |
Country Status (11)
Country | Link |
---|---|
US (1) | US10167284B2 (zh) |
EP (1) | EP3271358B1 (zh) |
JP (1) | JP6675415B2 (zh) |
CN (1) | CN107406449B (zh) |
AU (1) | AU2016231951B9 (zh) |
CA (1) | CA2979009C (zh) |
DK (1) | DK3271358T3 (zh) |
ES (1) | ES2852753T3 (zh) |
GB (1) | GB201504675D0 (zh) |
HK (1) | HK1248218A1 (zh) |
WO (1) | WO2016147011A1 (zh) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201402405QA (en) | 2011-11-18 | 2014-09-26 | Heptares Therapeutics Ltd | Muscarinic m1 receptor agonists |
GB201513740D0 (en) * | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonist |
GB201513743D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
WO2017107089A1 (en) | 2015-12-23 | 2017-06-29 | Merck Sharp & Dohme Corp. | 3- (1h-pyrazol-4-yl) pyridineallosteric modulators of the m4 muscarinic acetylcholine receptor |
EP3394061B1 (en) | 2015-12-23 | 2020-03-11 | Merck Sharp & Dohme Corp. | 6,7-dihydro-5h-pyrrolo[3,4-b]pyridin-5-one allosteric modulators of the m4 muscarinic acetylcholine receptor |
US10259787B2 (en) | 2016-10-14 | 2019-04-16 | Heptares Therapeutics Limited | Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists |
GB201617454D0 (en) * | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
WO2018112843A1 (en) | 2016-12-22 | 2018-06-28 | Merck Sharp & Dohme Corp. | Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor |
WO2018112842A1 (en) | 2016-12-22 | 2018-06-28 | Merck Sharp & Dohme Corp. | 6,6-fused heteroaryl piperidine ether allosteric modulators of m4 muscarinic acetylcholine receptor |
GB201709652D0 (en) * | 2017-06-16 | 2017-08-02 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
TW201922758A (zh) | 2017-10-24 | 2019-06-16 | 美商歐樂根公司 | 烯胺及烯胺的非鏡像選擇性還原 |
US11325896B2 (en) | 2017-12-20 | 2022-05-10 | Vanderbilt University | Antagonists of the muscarinic acetylcholine receptor M4 |
WO2019183636A1 (en) * | 2018-03-23 | 2019-09-26 | Pfizer Inc. | Piperazine azaspiro derivaves |
GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
PE20221454A1 (es) | 2019-10-09 | 2022-09-21 | Novartis Ag | Derivados de 2-azaespiro[3.4]octano como agonistas de m4 |
AU2020361735B2 (en) * | 2019-10-09 | 2024-04-18 | Novartis Ag | 2-azaspiro(3.4)octane derivatives as M4 agonists |
WO2023114224A1 (en) | 2021-12-13 | 2023-06-22 | Sage Therapeutics, Inc. | Combination of muscarinic receptor positive modulators and nmda positive allosteric modulators |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2206699A (en) * | 1997-12-23 | 1999-07-12 | Alcon Laboratories, Inc. | Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions |
KR20080087841A (ko) * | 2005-12-22 | 2008-10-01 | 버텍스 파마슈티칼스 인코포레이티드 | 무스카린 수용체의 조절제 |
US8673931B2 (en) * | 2009-01-26 | 2014-03-18 | Abraham Fisher | Bicyclic heterocyclic spiro compounds |
SG11201402405QA (en) * | 2011-11-18 | 2014-09-26 | Heptares Therapeutics Ltd | Muscarinic m1 receptor agonists |
US9266857B2 (en) * | 2012-09-18 | 2016-02-23 | Heptares Therapeutics Limited | Bicyclic AZA compounds as muscarinic M1 receptor agonists |
KR102352388B1 (ko) | 2014-02-06 | 2022-01-17 | 헵테얼즈 테라퓨틱스 리미티드 | 무스카린성 m1 수용체 및/또는 m4 수용체 작용제로서 바이사이클릭 아자 화합물 |
GB201404922D0 (en) | 2014-03-19 | 2014-04-30 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
-
2015
- 2015-03-19 GB GBGB1504675.8A patent/GB201504675D0/en not_active Ceased
-
2016
- 2016-03-21 US US15/559,375 patent/US10167284B2/en active Active
- 2016-03-21 DK DK16713022.8T patent/DK3271358T3/da active
- 2016-03-21 AU AU2016231951A patent/AU2016231951B9/en active Active
- 2016-03-21 CA CA2979009A patent/CA2979009C/en active Active
- 2016-03-21 CN CN201680016714.9A patent/CN107406449B/zh active Active
- 2016-03-21 WO PCT/GB2016/050771 patent/WO2016147011A1/en active Application Filing
- 2016-03-21 JP JP2017549261A patent/JP6675415B2/ja not_active Expired - Fee Related
- 2016-03-21 ES ES16713022T patent/ES2852753T3/es active Active
- 2016-03-21 EP EP16713022.8A patent/EP3271358B1/en active Active
-
2018
- 2018-06-11 HK HK18107567.8A patent/HK1248218A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
DK3271358T3 (da) | 2021-02-08 |
EP3271358B1 (en) | 2020-11-18 |
WO2016147011A1 (en) | 2016-09-22 |
US10167284B2 (en) | 2019-01-01 |
JP2018508562A (ja) | 2018-03-29 |
GB201504675D0 (en) | 2015-05-06 |
AU2016231951A1 (en) | 2017-09-28 |
AU2016231951B2 (en) | 2020-04-09 |
CA2979009A1 (en) | 2016-09-22 |
ES2852753T3 (es) | 2021-09-14 |
CN107406449A (zh) | 2017-11-28 |
EP3271358A1 (en) | 2018-01-24 |
JP6675415B2 (ja) | 2020-04-01 |
US20180072727A1 (en) | 2018-03-15 |
CN107406449B (zh) | 2020-11-10 |
AU2016231951B9 (en) | 2020-04-16 |
CA2979009C (en) | 2023-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1248218A1 (zh) | 作為毒蕈碱m1受體和/或m4受體的激動劑的螺環化合物 | |
HK1231473A1 (zh) | 作為毒蕈碱 和/或 受體激動劑的雙環氮雜化合物 | |
HK1253036A1 (zh) | 作為毒蕈碱m1和/或m4受體的激動劑的肟化合物 | |
HK1250160A1 (zh) | 毒蕈碱激動劑 | |
HK1255163A1 (zh) | 作為apj受體激動劑的雜芳基羥基嘧啶酮 | |
HK1231382A1 (zh) | 毒蕈碱受體激動劑 | |
IL248311B (en) | Compounds and preparations as agonists of toll-like receptor 7 | |
HK1250139A1 (zh) | 毒蕈碱激動劑 | |
AP2016009485A0 (en) | Compounds and compositions as toll-like receptor 7 agonists | |
HK1250138A1 (zh) | 毒蕈碱激動劑 | |
IL254476A0 (en) | Heterocyclylmethyl-thianouracil as adenosine-a2b receptor antagonists | |
IL252311A0 (en) | 4-oxo-4,3-dihydro-3,2,1-benzotriazines as G protein-coupled receptor modulators 139 | |
EP3265466A4 (en) | Peripheral-anticholinergic muscarinic agonist combination | |
PT3113774T (pt) | Composições de grapiprant e métodos de utilização das mesmas | |
ZA201607353B (en) | Bicyclic derivatives and pharmaceutical composition including the same | |
ZA201608823B (en) | Processes for the preparation of azd5363 and novel intermediate used therein |